William White

William White

William White joined InvestorPlace.com in 2013. He writes about a wide range of stocks across all industries, especially so-called “meme stocks” or “Reddit stocks.” Recently, his area of expertise has expanded to include cryptocurrencies, such as Bitcoin, Dogecoin, Ripple, and a myriad of other altcoins. Traders looking for additional insight into the stock market can follow him on Twitter.

Recent Articles

Why Is BiomX (PHGE) Stock Up 8% Today?

BiomX (PHGE) stock is rocketing on Wednesday following the release of the company's earnings report for the fourth quarter of 2022.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on!

SI Stock Alert: Short Squeeze Hopes Drive Silvergate Higher

Silvergate Capital (SI) stock is on the rise Tuesday as a potential short squeeze rally boils with a high short interest.

Why Is Oscar Health (OSCR) Stock Up 82% Today?

Oscar Health (OSCR) stock is heading higher on Tuesday after the healthcare company announced Mark Bertolini as its new CEO.

Paramount (PARA) Stock Pops on Analyst Upgrade

Paramount (PARA) stock is on the move Tuesday after the entertainment company got an upgrade from a Bank of America analyst.

LYFT Stock Alert: What to Know as Lyft Announces CEO Change

Lyft (LYFT) stock is a hot topic among traders on Tuesday after the ride-sharing company revealed a new CEO joining next month!

Why Is Alibaba (BABA) Stock Up 9% Today?

Alibaba (BABA) stock is on the rise Tuesday after the company revealed plans to split up into six businesses and become a holding company.

Why Is WiSA Technologies (WISA) Stock Down 32% Today?

WiSA Technologies (WISA) stock is falling on Tuesday but that's only after the company's shares underwent a rally yesterday.

Why Is Monopar Therapeutics (MNPR) Stock Down 47% Today?

Monopar Therapeutics (MNPR) stock is taking a beating on Tuesday after the company revealed lackluster clinical trial results.

Why Is Viking Therapeutics (VKTX) Stock Up 38% Today?

Viking Therapeutics (VKTX) stock is climbing higher on Tuesday after initiating a Phase 1 clinical trial of weight loss drug VK2735.